SEC Form D · filed March 3, 2015
Mersana Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
David Mott · CAMBRIDGE, MAExec · DirectorDonald Bergstrom · CAMBRIDGE, MAExecWayne J. Foster · CAMBRIDGE, MAExecSara J. Nayeem · CAMBRIDGE, MADirectorElaine J. Jones · CAMBRIDGE, MADirectorEva Jack · CAMBRIDGE, MAExecAnna Protopapas · CAMBRIDGE, MAExecThomas J. Beck · CAMBRIDGE, MADirectorTimothy Lowinger · CAMBRIDGE, MAExecJackalyne Pfannenstiel · San Francisco, CAExecAlvin H. Crawford, Jr · New York, NYExecBrian H. Madocks · New York, NYDirectorPeter Park · CAMBRIDGE, MAExecAndrew Trader · San Francisco, CAExec · DirectorThomas G. Mendell · New York, NYExec · DirectorGerardo Gomez De La Sierra · San Antonio, TXDirectorStacey Boyd · San Francisco, CAExec · DirectorScarlett O'Sullivan · San Francisco, CAExec · DirectorMariano Gomez De La Sierra · San Antonio, TXExec · DirectorDavid Milne · Boston, MAExecPaul Laviolette · Boston, MAExecKate Bingham · London, United KingdomExecPeter Park · CAMBRIDGE, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗